Jaime R Merchan

3PUBLICATIONS
42CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 22, 2026
Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors.

|Jan 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Robert J Motzer, Camillo Porta, Masatoshi Eto

|Aug 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.

Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky

Pageof 1

Frequent Collaborators

1 joint publications

Robert J Motzer

1 joint publications

Thomas Powles

1 joint publications

Viktor Grünwald

1 joint publications

Thomas E Hutson